ALG10

Alpha-1,2-glucosyltransferase involved in N-glycosylation and congenital disorders of glycosylation

Gene Information Card

Symbol ALG10
Full Name ALG10 alpha-1,2-glucosyltransferase
Gene Type Protein coding
Chromosomal Location 12p11.21
NCBI Gene ID 84920 ncbi.nlm.nih.gov/gene/84920
Ensembl ID ENSG00000139133
UniProt ID Q5BKT4
OMIM ID 609459
HGNC ID 23162
Aliases DIE2, KCR1, ALG10A, DIE2 (yeast homolog)

Description

ALG10 encodes alpha-1,2-glucosyltransferase, an enzyme that catalyzes the addition of the second glucose residue to the lipid-linked oligosaccharide (LLO) precursor during N-glycosylation. This reaction is essential for proper protein folding and quality control in the endoplasmic reticulum. Mutations in ALG10 cause a subtype of congenital disorders of glycosylation (CDG), characterized by defective N-glycan assembly.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital disorder of glycosylation type I (ALG10-CDG) Deficient ALG10 activity impairs LLO biosynthesis, leading to hypoglycosylation of proteins. OMIM #609459; ClinVar; PMID: 20533528
ALG10-CDG with neurological involvement Loss of ALG10 function disrupts neuronal glycosylation, causing developmental delay and seizures. OMIM #609459; PMID: 20533528

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 8.2 Medium
Brain 6.5 Medium
Kidney 5.1 Low
Heart 4.8 Low
Pancreas 3.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 7.1 nTPM from GTEx
HepG2 6.8 nTPM from GTEx
K562 4.2 nTPM from GTEx
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1070G>A (p.Arg357His) Missense Rare Reduced enzymatic activity; associated with CDG
c.1243C>T (p.Arg415Trp) Missense Rare Loss of function; reported in ALG10-CDG
c.1A>G (p.Met1Val) Start loss Rare Complete loss of protein; pathogenic
Mutation functional classification

Loss of Function (LOF)

Missense and start-loss mutations reduce or abolish glucosyltransferase activity, leading to LLO truncation and hypoglycosylation.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations reported.

Gene Ontology (GO)

• GO:0006487 – protein N-linked glycosylation • GO:0004582 – dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase activity
• GO:0005789 – endoplasmic reticulum membrane • GO:0016021 – integral component of membrane

Pathways

KEGG hsa00510 – N-Glycan biosynthesis
Reactome R-HSA-446203 – Asparagine N-linked glycosylation

Protein Summary

ALG10 is a 526-amino acid transmembrane protein localized to the endoplasmic reticulum membrane. It functions as a dolichyl-phosphate-glucose-dependent glucosyltransferase, transferring glucose from dolichyl-phosphate-glucose to the growing LLO. The protein is essential for the final steps of LLO assembly before transfer to nascent polypeptides.

Related Products

Product name Cat.No. Species Gene ID
ALG10 Knockout HEK293 Cell Line EDJ-KQ10257 Human 84920 Details Get a Quote
ALG10B Knockout HEK293 Cell Line EDJ-KQ10409 Human 144245 Details Get a Quote
ALG10 Knockout A-549 Cell Line EDJ-KQ37474 Human 84920 Details Get a Quote
ALG10 Knockout HCT 116 Cell Line EDJ-KQ37475 Human 84920 Details Get a Quote
ALG10 Knockout HeLa Cell Line EDJ-KQ37476 Human 84920 Details Get a Quote
ALG10B Knockout A-549 Cell Line EDJ-KQ37765 Human 144245 Details Get a Quote
ALG10B Knockout HCT 116 Cell Line EDJ-KQ37766 Human 144245 Details Get a Quote
ALG10B Knockout HeLa Cell Line EDJ-KQ37767 Human 144245 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: